Article
- The EMBO Journal (2005) 24, 2968 - 2979
- doi:10.1038/sj.emboj.7600771
Published online: 4 August 2005
Subject Categories:
Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule
Yili Li1, Yuping Huang1, Jessica Lue1, Jacqueline A Quandt2, Roland Martin2 and Roy A Mariuzza1
- Center for Advanced Research in Biotechnology, WM Keck Laboratory for Structural Biology, University of Maryland Biotechnology Institute, Rockville, MD, USA
- Cellular Immunology Section, Neuroimmunology Branch, National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, MD, USA
Correspondence to:
Roy A Mariuzza, Center for Advanced Research in Biotechnology, WM Keck Laboratory for Structural Biology, University of Maryland Biotechnology Institute, 9600 Gudelsky Drive, Rockville, MD 20850, USA. Tel.: +1 301 738 6243; Fax: +1 301 738 6255; E-mail: mariuzza@carb.nist.gov
Received 17 May 2005; Accepted 14 July 2005
Abstract
Multiple sclerosis is mediated by T-cell responses to central nervous system antigens such as myelin basic protein (MBP). To investigate self-peptide/major histocompatibility complex (MHC) recognition and T-cell receptor (TCR) degeneracy, we determined the crystal structure, at 2.8 Å resolution, of an autoimmune TCR (3A6) bound to an MBP self-peptide and the multiple sclerosis-associated MHC class II molecule, human leukocyte antigen (HLA)-DR2a. The complex reveals that 3A6 primarily recognizes the N-terminal portion of MBP, in contrast with antimicrobial and alloreactive TCRs, which focus on the peptide center. Moreover, this binding mode, which may be frequent among autoimmune TCRs, is compatible with a wide range of orientation angles of TCR to peptide/MHC. The interface is characterized by a scarcity of hydrogen bonds between TCR and peptide, and TCR-induced conformational changes in MBP/HLA-DR2a, which likely explain the low observed affinity. Degeneracy of 3A6, manifested by recognition of superagonist peptides bearing substitutions at nearly all TCR-contacting positions, results from the few specific interactions between 3A6 and MBP, allowing optimization of interface complementarity through variations in the peptide.
Keywords:
- autoimmunity,
- complex,
- MHC class II,
- multiple sclerosis,
- T-cell receptor
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
MHC class II proteins and disease: a structural perspective
Nature Reviews Immunology Review (01 Apr 2006)
NEWS AND VIEWS
MHC restriction: slip-sliding away
Nature Immunology News and Views (01 May 2005)
HLA class I: friend and foe of multiple sclerosis
Nature Medicine News and Views (01 Nov 2008)
RESEARCH
Abolition of specific immune response defect by immunization with dendritic cells
Nature Letters to Editor (07 Nov 1985)
Responsiveness of plasma renin and aldosterone in diabetes mellitus
Kidney International Original Article
